HHS: 340B Restrictions 'Akin To Letting The Fox Guard The Henhouse'

Several hospital lobbies filed briefs Monday (May 16) in support of the government’s appeals to lower court rulings that could determine whether drug companies are allowed to restrict discounts to hospitals in the 340B drug discount program. HHS maintains its stance that drug companies may not deny discounts when hospitals use multiple contract pharmacies and says that letting drug companies set the rules of the program is “akin to letting the fox guard the henhouse.” Hospitals agree. “What drugmakers are...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 05/23/2022
IDP Volume: 
Vol. 5, No. 21
Author: 

Maine Is Third State To Consider Making Its Own Insulin

The University of Maine might make insulin or partner with a commercial drug manufacturer to make it. Maine recently passed a bill to form a commission that will assess the feasibility of the university spearheading insulin manufacturing for the state. State Sen. Trey Stewart (R) said the legislature has also been looking into partnering with other states to manufacture and distribute generic drugs because Maine may be too small to make an impact on the drug market on its own...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 05/23/2022
IDP Volume: 
Vol. 5, No. 21
Author: 

Virtual Tools Touted To Build Teleprescribing Support In Wake Of Cerebral Probe

Amid the firestorm of controversy surrounding Cerebral’s alleged improper telehealth prescribing of ADHD pills, some experts view virtual prescribing tools that provide standardized patient assessments as a way to separate bad actors and build support for continued prescribing of controlled substances by legitimate telehealth providers after the pandemic ends. The Drug Enforcement Administration’s recent decision to investigate whether Cerebral overprescribed ADHD treatment led the health start-up, which offers treatment and prescription medications exclusively via telehealth, to permanently stop prescribing almost...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 










Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.